Get started
Work

Supplementary Table 2 from Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide

Year: 2023
Type: supplementary-materials
Abstract: Summary of mean (%CV) PK parameters of Total ADC and Active ADC after a single IV infusion of MEDI3726
DOI: 10.1158/1078-0432.22481336.v1
Authors: Johann S. de Bono, Mark T. Fleming, Judy S. Wang, Richard Cathomas, Manuel Selvi Miralles, John Bothos, Mary Jane Hinrichs, Qu Zhang, Peng He, Marna Williams, Anton I. Rosenbaum, Meina Liang, Kapil Vashisht, Song Cho, Pablo Martinez, Daniel P. Petrylak
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361863709
Cites:
Cited by:
Related to: 10